Press release
House Dust Mite Allergy Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
In the House Dust Mite Allergy Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, House Dust Mite Allergy NDA approvals (if any), and product development activities comprising the technology, House Dust Mite Allergy collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Key takeaways from the House Dust Mite Allergy Pipeline Report
• House Dust Mite Allergy Pipeline report offers a comprehensive analysis of 5+ companies and 5+ therapies.
• The leading House Dust Mite Allergy Companies includes T-Balance Therapeutics, Worg Pharmaceuticals, Advagene Biopharma Co., Ltd., Immunotek SL, Tolerogenics S.à.r.l., Foresee Pharmaceuticals, and others.
• Promising House Dust Mite Allergy Pipeline Therapies includes AIT Tablet, hdmASIT+TM, SUBLIVAC FIX Mite mixture, CYT005-AllQbG10, Dispersible Tablet, SLIT tablets of HDM allergen extracts, 3 different doses (A), and others.
• The House Dust Mite Allergy Companies and academics that are working to assess challenges and seek opportunities that could influence House Dust Mite Allergy R&D. The House Dust Mite Allergy pipeline therapies under development are focused on novel approaches to treat/improve the disease condition.
Explore more information on the latest breakthroughs in the House Dust Mite Allergy treatment landscape of the report and House Dust Mite Allergy Pipeline Outlook @ https://www.delveinsight.com/sample-request/house-dust-mite-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
House Dust Mite Allergy Overview
Dust mite allergy is an allergic condition that occurs as a reaction to the dust mite allergens that commonly live in household dust. It is also known as house dust allergy. It is sensitization and an allergic reaction to the droppings of the dust mites. The droppings are an indoor aeroallergen, which on inhalation triggers the allergic reaction. The prevalence of atopic diseases like allergic rhinitis and asthma with house dust mite being the allergen has been increasing. House dust allergy was first identified as an allergen around 1920. In 1967, Voorhorst et al. identified Dermatophagoides pteronyssinus as the causative allergen for house dust allergy.
House Dust Mite Allergy Emerging Drugs Profile
Tregalizumab: T-Balance Therapeutics
Tregalizumab selectively activates the immunomodulatory subpopulation of T cells called regulatory T cells or Tregs. Tregs are essential for maintaining peripheral immune tolerance; they suppress autoreactive T cells (i.e. cells targeted against the body's own structures) and thereby prevent the excessive activation of T lymphocytes seen in autoimmune and inflammatory diseases. Tregalizumab acts early in the inflammatory cascade, providing the opportunity for a novel therapeutic approach aimed at the prevention and treatment of inflammatory conditions.
FP-025: Foresee Pharmaceuticals
FP-025 is a highly selective (non-hydroxamate), oral non-competitive small molecule inhibitors of Matrix Metalloproteinase-12/Macrophage elastase (MMP-12), an enzyme that acts as a key mediator of matrix degradation and remodeling in both normal development and maintenance. FP-025 is well tolerated in healthy human volunteers and allergic asthmatic patients upon single and repeat dosing, and exhibits good single and multiple dose oral pharmacokinetics.
Request a sample and discover the recent advances in House Dust Mite Allergy Pipeline Therapies, visit House Dust Mite Allergy Treatment Landscape @ https://www.delveinsight.com/sample-request/house-dust-mite-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
House Dust Mite Allergy Pipeline Therapeutics Assessment
There are approx. 5+ key companies which are developing the therapies for House Dust Mite Allergy. The companies which have their House Dust Mite Allergy drug candidates in the most advanced stage, i.e. phase II include, T-Balance Therapeutics.
House Dust Mite Allergy Pipeline Segmentation
Phases
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• NA
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Get to know more information about the House Dust Mite Allergy Emerging Drugs and Companies of the report @ https://www.delveinsight.com/sample-request/house-dust-mite-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the House Dust Mite Allergy Pipeline Report
• Coverage- Global
• House Dust Mite Allergy Companies- T-Balance Therapeutics, Worg Pharmaceuticals, Advagene Biopharma Co., Ltd., Immunotek SL, Tolerogenics S.à.r.l., Foresee Pharmaceuticals, and others.
• House Dust Mite Allergy Pipeline Therapies- AIT Tablet, hdmASIT+TM, SUBLIVAC FIX Mite mixture, CYT005-AllQbG10, Dispersible Tablet, SLIT tablets of HDM allergen extracts, 3 different doses (A), and others.
• House Dust Mite Allergy Pipeline Segmentation: Product Type, Route of Administration, Mechanism of Action, Molecule Type
To know more facts about the House Dust Mite Allergy Pipeline Insights Report, View here- House Dust Mite Allergy Unmet Needs and Analyst Views @ https://www.delveinsight.com/sample-request/house-dust-mite-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. House Dust Mite Allergy: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. House Dust Mite Allergy - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name: Company name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Tregalizumab: T-Balance Therapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Drug name: Company name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. WP1049: Worg Pharmaceuticals
18. Drug profiles in the detailed report…..
19. Inactive Products
20. House Dust Mite Allergy Key Companies
21. House Dust Mite Allergy Key Products
22. House Dust Mite Allergy- Unmet Needs
23. House Dust Mite Allergy- Market Drivers and Barriers
24. House Dust Mite Allergy- Future Perspectives and Conclusion
25. House Dust Mite Allergy Analyst Views
26. House Dust Mite Allergy Key Companies
27. Appendix
For further information, refer to the detailed House Dust Mite Allergy Pipeline report, visit House Dust Mite Allergy Emerging Drugs & Companies @ https://www.delveinsight.com/sample-request/house-dust-mite-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Trending Market Research Reports 2032 | DelveInsight
Technical Due Diligence Firms- https://www.delveinsight.com/consulting/due-diligence-services
Vital Sign Monitors Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Anastomosis Device Market- https://www.delveinsight.com/report-store/anastomotic-leak-devices-market
Asperger Syndrome Market- https://www.delveinsight.com/report-store/asperger-syndrome-market
B-Cell Maturation Antigen Targeted Therapies Market- https://www.delveinsight.com/report-store/b-cell-maturation-antigen-targeted-therapies-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Oncolytic Virus Cancer Therapy Pipeline- https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Shingles Market- https://www.delveinsight.com/report-store/shingles-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Tay-Sachs Disease Market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Shigellosis Market- https://www.delveinsight.com/report-store/shigellosis-market
Gene Therapy In CNS Disorder Market- https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
Hypertrophic Cardiomyopathy Market- https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
Varicella Zoster (HHV-3) Infections Market- https://www.delveinsight.com/report-store/varicella-zoster-hhv-3-infections-market
Vasculitis Market- https://www.delveinsight.com/report-store/vasculitis-market
Vascular Imaging Devices Market- https://www.delveinsight.com/report-store/vascular-imaging-market-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release House Dust Mite Allergy Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 2900987 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Mite
House Dust Mite Allergy Market Report 2024 - House Dust Mite Allergy Market Grow …
"The Business Research Company recently released a comprehensive report on the Global House Dust Mite Allergy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The house…
Household Ultraviolet Mite Removal Instrument
Global Household Ultraviolet Mite Removal Instrument Market Overview
The Household Ultraviolet Mite Removal Instrument market is a diverse and rapidly evolving industry that encompasses a wide range of products and services. It is characterized by intense competition, changing consumer preferences, and technological advancements that continually drive innovation.
The Household Ultraviolet Mite Removal Instrument market is comprised of several sub-sectors, including but not limited to: electronics, healthcare, automotive, consumer goods, and energy. Each…
Handheld UV Mite Removal Instrument Market: Increasing Concerns Regarding Allerg …
Global Handheld UV Mite Removal Instrument Market Overview:
The Handheld UV Mite Removal Instrument market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Handheld UV Mite Removal Instrument market has experienced significant growth, driven by factors such as increasing consumer demand,…
Mite Predators Market Overview by 2025 | Dyson, Midea, Panasonic
QY Research indicates that the global Mite Predators market is expected to surge at a steady rate in the coming years, as economies flourish. The research report, Mite Predators market provides a comprehensive review of the global market. Analysts have identified the key drivers and restraints in the overall market. They have studied the historical milestones achieved by the global Mite Predators market and emerging trends. A comparison of the…
Global Mite Predators Market 2019 - Panasonic, Haier, SUPOR, LEXY, Deerma
Mite Predators are designed to eliminate bacteria, viruses, mites, etc. that breed on beds, sofas, carpets, clothing, and any textile items.
Get Free Sample Copy of Report Here: https://bit.ly/2T7HlTi
Scope of the Report:
In addition to the special frequency of ultrasonic waves on the physiological system of the mites, the mite predators can resonate and effectively suppress the feeding and breeding process in the life cycle of the dust mites, thereby reducing the…
Global Dust Mite Controller Market 2019 - Panasonic, Haier, SUPOR, LEXY
Dust Mite Controller can produce up to 40 megahertz of ultrasound that is inaudible to the human ear.
Get Free Sample Copy of Report Here: https://bit.ly/2MkDVKb
Scope of the Report:
In addition to the special frequency of ultrasonic waves on the physiological system of the mites, the dust mite controller can resonate and effectively suppress the feeding and breeding process in the life cycle of the dust mites, thereby reducing the dust mites…
